How the cannabis judgment reshaped South African drug policy

South Africa's approach to drug control has historically been characterised by strict prohibition, primarily enforced through the Medicines and Related Substances Act and the Drugs and Drug Trafficking Act. Under this framework, the personal use, possession, and cultivation of almost all psychoactive substances have carried severe criminal penalties. However, the legal landscape shifted significantly in 2018 when the Constitutional Court of South Africa ruled that criminalising the personal use of cannabis by adults was unconstitutional. While this ruling applied specifically to cannabis, it introduced a fundamental rights-based reasoning into South African drug policy. For advocates of other controlled substances, such as psilocybin, the judgment has become a critical reference point and a potential legal template for broader reform.

The Constitutional Right to Privacy

The landmark 2018 judgment in *Minister of Justice and Constitutional Development v Prince* centred on Section 14 of the South African Constitution, which protects the right to privacy. Several individuals challenged the laws criminalising cannabis, arguing that the state had no right to police what consenting adults did in the privacy of their own homes, provided it caused no harm to others. The Constitutional Court agreed. The justices found that criminalising the personal possession and consumption of cannabis by adults in private spaces unjustifiably infringed on this right to privacy.

In reaching this conclusion, the court applied a constitutional proportionality test. While the state argued that criminalisation was necessary to protect public health, the court ruled that prosecuting and imprisoning individuals for private, non-violent conduct was a disproportionate response. Importantly, the ruling decriminalised personal use in private, but it did not legalise the substance entirely; public use, commercial dealing, and use by minors remained strictly prohibited.

Parliament's Response and the Limits of Reform

Following the Constitutional Court's ruling, Parliament was given a period of time to amend the relevant legislation to bring it into alignment with the judgment. This legislative process eventually produced the Cannabis for Private Purposes Act, which seeks to regulate the private cultivation, possession, and use of cannabis by adults, while maintaining strict criminal penalties for dealing and public consumption.

However, the cannabis precedent has distinct legal limits. It did not establish a commercial, regulated market for the substance, nor did it remove cannabis entirely from the regulatory oversight of the South African Health Products Regulatory Authority (SAHPRA) for medical and scientific purposes. The precedent established was therefore narrowly focused on personal autonomy and the right to privacy in one's home, rather than a blanket endorsement of substance use.

A Template for Psilocybin Policy?

Because psilocybin is currently classified as a Schedule 7 substance under the Medicines Act—the most restrictive category, generally reserved for substances with a high potential for abuse and no recognised therapeutic use—reform advocates frequently look to the cannabis judgment as a legal template. The core argument is that the constitutional right to privacy should not logically be limited to a single substance. If the state cannot justify criminalising an adult for possessing and using cannabis in their home, advocates argue that the same privacy protections should extend to other substances, including psilocybin.

Proponents of psilocybin policy reform suggest that the personal, private use of a controlled substance is a matter of individual autonomy, and that the criminal justice system is an inappropriate tool for managing private behaviour. They argue that drug policy should shift from a punitive criminal justice model to a public health and regulatory model, a shift the cannabis ruling partially achieved by prioritising constitutional rights over blanket prohibition.

Hurdles to Extending the Precedent

Despite the optimism of reform advocates, extending the cannabis precedent to psilocybin faces significant legal and public health hurdles. The Constitutional Court was careful to base its cannabis ruling on the specific facts and evidence presented in that case, which included extensive testimony about the plant's cultural and historical context in South Africa. Legal scholars often point out that courts may be reluctant to automatically apply the same privacy reasoning to other, less culturally ubiquitous substances.

Furthermore, regulators like SAHPRA and the Department of Health maintain that different substances carry distinct pharmacological risks. The state may successfully argue that the privacy interest in using a Schedule 7 substance like psilocybin is outweighed by the government's duty to protect public health, particularly given current legal categorisations. Consequently, while the cannabis judgment reshaped the language of South African drug policy by elevating privacy rights, translating that precedent to other controlled substances remains an open and complex legal challenge.